Objective:

To analyze patient-pharmacist interactions in allogeneic stem cell transplant recipients using a specific mHealth platform and to evaluate busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation.

Key Findings:

• Pharmacists reviewed 297 drugs for 22 patients, with 70.7% activated by patients.
• Pharmacists sent 118 messages, indicating active communication with patients.
• In the busulfan study, the effectiveness of TDM regimens on achieving target exposure was evaluated, with specific outcomes to be detailed.

Interpretation:

The mHealth tool improved medication management and communication between pharmacists and allo-SCT patients. The busulfan study aimed to optimize dosing through TDM, with implications for pediatric care.

Limitations:

• The pilot study had a small sample size of 28 patients.
• The observational nature of the busulfan study may limit generalizability, and potential biases should be considered.

Conclusion:

Pharmacist involvement via mHealth tools can enhance patient care in allo-SCT, and TDM may improve busulfan exposure in pediatric patients, as evidenced by the findings.